Variant position: 878 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1363 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human KVVEASAFGIHKGSSCDTVA VKMLKEGATASEHRALMSELK
Mouse KVVEASAFGINKGSSCDTVA VKMLKEGATASEHRALMSELK
Rat KVVEASAFGINKGSSCDTVA VKMLKEGATASEHRALMSELK
Zebrafish KVIEASIFGHDKKSSANTVA VKMLKEGATASEHKALMSELK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
25 – 1363 Vascular endothelial growth factor receptor 3
797 – 1363 Cytoplasmic
845 – 1173 Protein kinase
879 – 879 ATP
766 – 1298 Missing. In isoform 3.
879 – 879 K -> G. Abolishes enzyme activity.
Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations.
Ghalamkarpour A.; Morlot S.; Raas-Rothschild A.; Utkus A.; Mulliken J.B.; Boon L.M.; Vikkula M.;
Clin. Genet. 70:330-335(2006)
Cited for: VARIANTS LMPHM1 MET-878; THR-1086 AND PHE-1108 DEL; VARIANT GLN-1035; INVOLVEMENT IN LMPHM1;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.